134 related articles for article (PubMed ID: 38149553)
21. Detection of Mycobacterium leprae by PCR testing of sputa from a patient with pulmonary cryptococcus coinfection in northern Australia.
Edwards LJ; Price RN; Krause VL; Huffam SE; Globan M; Fyfe J; Hajkowicz KM
J Clin Microbiol; 2014 Oct; 52(10):3811-2. PubMed ID: 25056325
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to diverse lipids in the serum of patients with clinically cured leprosy and tuberculosis.
Rojas-Espinosa O; Arenas R; Arce-Parades P; Miranda-Contreras G
Acta Leprol; 2003; 12(3):112-6. PubMed ID: 15040701
[TBL] [Abstract][Full Text] [Related]
23. Leprosy and HIV coinfection: a critical approach.
Massone C; Talhari C; Ribeiro-Rodrigues R; Sindeaux RH; Mira MT; Talhari S; Naafs B
Expert Rev Anti Infect Ther; 2011 Jun; 9(6):701-10. PubMed ID: 21692674
[TBL] [Abstract][Full Text] [Related]
24. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
25. Association of
Li S; Wang X; Zhao Y; Yang J; Cui T; Zhao ZJ; Chen Y; Zheng Z
Front Immunol; 2021; 12():592841. PubMed ID: 33717071
[TBL] [Abstract][Full Text] [Related]
26. Management of sulphone-resistant lepromatous leprosy.
Jopling WH
Lepr Rev; 1977 Jun; 48(2):127-8. PubMed ID: 330998
[No Abstract] [Full Text] [Related]
27. Chest infection due to M. fortuitum in a case of lepromatous leprosy--a case report.
Katoch K; Katoch VM; Dutta AK; Sharma VD; Ramu G
Indian J Lepr; 1985; 57(2):399-403. PubMed ID: 4078368
[TBL] [Abstract][Full Text] [Related]
28. Defective monocyte chemotaxis in active lepromatous leprosy.
Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
[TBL] [Abstract][Full Text] [Related]
29. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
[TBL] [Abstract][Full Text] [Related]
30. Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.
Labuda SM; Schieffelin JS; Shaffer JG; Stryjewska BM
Am J Trop Med Hyg; 2017 Dec; 97(6):1726-1730. PubMed ID: 29141716
[TBL] [Abstract][Full Text] [Related]
31. American cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response.
Delobel P; Launois P; Djossou F; Sainte-Marie D; Pradinaud R
Clin Infect Dis; 2003 Sep; 37(5):628-33. PubMed ID: 12942392
[TBL] [Abstract][Full Text] [Related]
32. Enzyme-linked immunosorbent assay (ELISA) with mycobacterial crude antigens for the sero-epidemiological diagnosis of active tuberculosis.
Escobar-Gutierrez A; Amezcua-Chavarria ME; Pasten-Sanchez S; Ramirez-Casanova E; Cazares JV; Granados G; Loo-Mendez E; Cicero R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):417-27. PubMed ID: 9030108
[TBL] [Abstract][Full Text] [Related]
33. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
34. Fatal reaction to dapsone during treatment of leprosy.
Frey HM; Gershon AA; Borkowsky W; Bullock WE
Ann Intern Med; 1981 Jun; 94(6):777-9. PubMed ID: 7235421
[TBL] [Abstract][Full Text] [Related]
35. Coinfection with Leprosy and Tuberculosis: A Case Series in Malagasy Patients.
Rakotoarisaona MF; Razafimaharo TI; Sendrasoa FA; Andrianarison M; Razanakoto NH; Ratovonjanahary VT; Raharolahy O; Ranaivo IM; Ramarozatovo LS; Rapelanoro Rabenja F
Infect Drug Resist; 2024; 17():1507-1513. PubMed ID: 38645889
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
Roche PW; Prestidge RL; Watson JD; Britton WJ
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
[TBL] [Abstract][Full Text] [Related]
37. Leprosy Caused by Mycobacterium lepromatosis.
Romero-Navarrete M; Arenas R; Han XY; Vega-Memije ME; Castillo-Solana AD
Am J Clin Pathol; 2022 Dec; 158(6):678-686. PubMed ID: 36200553
[TBL] [Abstract][Full Text] [Related]
38. False-positive amplified Mycobacterium tuberculosis direct test results for samples containing Mycobacterium leprae.
Chedore P; Broukhanski G; Shainhouse Z; Jamieson F
J Clin Microbiol; 2006 Feb; 44(2):612-3. PubMed ID: 16455924
[TBL] [Abstract][Full Text] [Related]
39. Peripheral edema in lepromatous leprosy--could thalidomide be the culprit.
Mehta V
Indian J Lepr; 2008; 80(4):345-6. PubMed ID: 20329383
[No Abstract] [Full Text] [Related]
40. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
